Cargando…
Complication of coronavirus disease 2019 during remission induction therapy against anti-MDA5 antibody-positive dermatomyositis
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717435/ https://www.ncbi.nlm.nih.gov/pubmed/33336141 http://dx.doi.org/10.1093/rap/rkaa068 |
_version_ | 1783619311000092672 |
---|---|
author | Kogami, Masahiro Suzuki, Satoshi Nanjo, Yuta Ikeda, Keigo Tamura, Naoto Sasaki, Shinichi Morimoto, Shinji |
author_facet | Kogami, Masahiro Suzuki, Satoshi Nanjo, Yuta Ikeda, Keigo Tamura, Naoto Sasaki, Shinichi Morimoto, Shinji |
author_sort | Kogami, Masahiro |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7717435 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-77174352020-12-09 Complication of coronavirus disease 2019 during remission induction therapy against anti-MDA5 antibody-positive dermatomyositis Kogami, Masahiro Suzuki, Satoshi Nanjo, Yuta Ikeda, Keigo Tamura, Naoto Sasaki, Shinichi Morimoto, Shinji Rheumatol Adv Pract Letter to the Editor (Case report) Oxford University Press 2020-11-17 /pmc/articles/PMC7717435/ /pubmed/33336141 http://dx.doi.org/10.1093/rap/rkaa068 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Letter to the Editor (Case report) Kogami, Masahiro Suzuki, Satoshi Nanjo, Yuta Ikeda, Keigo Tamura, Naoto Sasaki, Shinichi Morimoto, Shinji Complication of coronavirus disease 2019 during remission induction therapy against anti-MDA5 antibody-positive dermatomyositis |
title | Complication of coronavirus disease 2019 during remission induction therapy against anti-MDA5 antibody-positive dermatomyositis |
title_full | Complication of coronavirus disease 2019 during remission induction therapy against anti-MDA5 antibody-positive dermatomyositis |
title_fullStr | Complication of coronavirus disease 2019 during remission induction therapy against anti-MDA5 antibody-positive dermatomyositis |
title_full_unstemmed | Complication of coronavirus disease 2019 during remission induction therapy against anti-MDA5 antibody-positive dermatomyositis |
title_short | Complication of coronavirus disease 2019 during remission induction therapy against anti-MDA5 antibody-positive dermatomyositis |
title_sort | complication of coronavirus disease 2019 during remission induction therapy against anti-mda5 antibody-positive dermatomyositis |
topic | Letter to the Editor (Case report) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717435/ https://www.ncbi.nlm.nih.gov/pubmed/33336141 http://dx.doi.org/10.1093/rap/rkaa068 |
work_keys_str_mv | AT kogamimasahiro complicationofcoronavirusdisease2019duringremissioninductiontherapyagainstantimda5antibodypositivedermatomyositis AT suzukisatoshi complicationofcoronavirusdisease2019duringremissioninductiontherapyagainstantimda5antibodypositivedermatomyositis AT nanjoyuta complicationofcoronavirusdisease2019duringremissioninductiontherapyagainstantimda5antibodypositivedermatomyositis AT ikedakeigo complicationofcoronavirusdisease2019duringremissioninductiontherapyagainstantimda5antibodypositivedermatomyositis AT tamuranaoto complicationofcoronavirusdisease2019duringremissioninductiontherapyagainstantimda5antibodypositivedermatomyositis AT sasakishinichi complicationofcoronavirusdisease2019duringremissioninductiontherapyagainstantimda5antibodypositivedermatomyositis AT morimotoshinji complicationofcoronavirusdisease2019duringremissioninductiontherapyagainstantimda5antibodypositivedermatomyositis |